Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-09-19 4:30 pm Unchanged | 2022-09-19 | 13G | SpringWorks Therapeutics, Inc. SWTX | Boxer Capital LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-06-15 7:11 pm Unchanged | 2022-06-15 | 13D | Tyra Biosciences, Inc. TYRA | Boxer Capital LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-05-11 5:14 pm Unchanged | 2022-05-11 | 13D | iTeos Therapeutics, Inc. ITOS | Boxer Capital LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-03-18 9:00 pm Unchanged | 2022-03-18 | 13D | iTeos Therapeutics, Inc. ITOS | Boxer Capital LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-02-14 4:54 pm Unchanged | 2022-02-14 | 13G | Milestone Pharmaceuticals Inc. MIST | Boxer Capital LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-02-14 4:47 pm Unchanged | 2022-02-14 | 13G | Atreca, Inc. BCEL | Boxer Capital LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-02-14 4:43 pm Unchanged | 2022-02-14 | 13G | Matinas BioPharma Holdings, Inc. MTNB | Boxer Capital LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-02-14 4:40 pm Unchanged | 2022-02-14 | 13G | Solid Biosciences Inc. SLDB | Boxer Capital LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-02-14 4:40 pm Unchanged | 2022-02-14 | 13G | Mereo BioPharma Group plc MREO | Boxer Capital LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-02-14 4:40 pm Unchanged | 2022-02-14 | 13G | Cabaletta Bio, Inc. CABA | Boxer Capital LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-02-14 4:36 pm Unchanged | 2022-02-14 | 13G | DBV Technologies S.A. DBVT | Boxer Capital LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-02-14 4:33 pm Unchanged | 2022-02-14 | 13G | ARS Pharmaceuticals, Inc. SPRY | Boxer Capital LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-02-14 4:28 pm Unchanged | 2022-02-14 | 13G | Marinus Pharmaceuticals, Inc. MRNS | Boxer Capital LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-02-14 4:22 pm Unchanged | 2022-02-14 | 13G | CymaBay Therapeutics, Inc. CBAY | Boxer Capital LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-02-14 4:21 pm Unchanged | 2022-02-14 | 13G | Elevation Oncology, Inc. ELEV | Boxer Capital LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-02-14 4:19 pm Unchanged | 2022-02-14 | 13G | F-star Therapeutics, Inc. FSTX | Boxer Capital LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-02-14 4:17 pm Unchanged | 2022-02-14 | 13G | POINT Biopharma Global Inc. PNT | Boxer Capital LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-02-14 4:16 pm Unchanged | 2022-02-14 | 13G | PMV Pharmaceuticals, Inc. PMVP | Boxer Capital LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-02-14 4:14 pm Unchanged | 2022-02-14 | 13G | Talis Biomedical Corporation TLIS | Boxer Capital LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-02-14 4:10 pm Unchanged | 2022-02-14 | 13G | Biomea Fusion, Inc. BMEA | Boxer Capital LLC | 0 0.000% | 0 (Unchanged) | Filing |